Status:

COMPLETED

Nasal LPS Challenge in Healthy Volunteers

Lead Sponsor:

Imperial College London

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Healthy

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

The purpose of this study is to develop a nasal challenge model that causes a mild degree of inflammation, without causing any pain or symptoms, but that allows us to measure a variety of proteins in ...

Detailed Description

STUDY DESIGN AND METHODOLOGY This is a single-centre study which will be carried out at the Imperial Clinical Respiratory Research Unit (ICRRU) at St Mary's Hospital in London Paddington. RECRUITMENT...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA
  • Males and females aged 18 to 60 years
  • Current non-smokers for last 6 months (\<5 cigs per week), with a smoking history of \<5 pack years
  • BMI 20-30 kg/m2
  • EXCLUSION CRITERIA
  • History of allergy
  • Upper airway infection in 2 weeks before screening
  • Lower respiratory tract infection in past 3 months
  • Treatment with local or systemic corticosteroids during previous 2 months
  • Signs or symptoms of chronic rhinitis, hypertrophy of turbinates, major septum deviation, nasal polyposis or recurrent sinusitis
  • Previous nasal or sinus surgery
  • Clinically significant cardiovascular, hepatic, GIT, renal, endocrine, infective, haematological, neurological, dermatological, neoplastic conditions, gastro-oesophageal reflux, depression, TB
  • Participation in a therapeutic drug trial in the prior 30 days.
  • Medical therapy other than that permitted for contraception.
  • Positive pregnancy test
  • Inability or unwillingness to use contraception if the patient is a female of child-bearing age.
  • History of drug abuse or urine test showing evidence of recreational drug abuse

Exclusion

    Key Trial Info

    Start Date :

    October 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2011

    Estimated Enrollment :

    15 Patients enrolled

    Trial Details

    Trial ID

    NCT02284074

    Start Date

    October 1 2010

    End Date

    April 1 2011

    Last Update

    September 15 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's Hospital

    Paddington, London, United Kingdom, W2 1NY